KMT2D AND TP53 MUTATIONS PREDICT POOR PFS AND OS IN MANTLE CELL LYMPHOMA RECEIVING HIGH‐DOSE THERAPY AND ASCT: THE FONDAZIONE ITALIANA LINFOMI (FIL) MCL0208 PHASE III TRIAL
Gespeichert in:
| Veröffentlicht in: | Hematological oncology 2017-06, Vol.35 (S2), p.94-95 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 95 |
|---|---|
| container_issue | S2 |
| container_start_page | 94 |
| container_title | Hematological oncology |
| container_volume | 35 |
| creator | Ferrero, S. Rossi, D. Bruscaggin, A. Evangelista, A. Di Rocco, A. Spina, V. Stefoni, V. Ghione, P. Barbero, D. Monitillo, L. Gomes Da Silva, M. Santoro, A. Molinari, A. Ferreri, A. Piccin, A. Cortelazzo, S. Ladetto, M. Gaidano, G. |
| description | |
| doi_str_mv | 10.1002/hon.2437_83 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1906638508</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1906638508</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1873-baed220cf1874ff9c8029601f1cc7af4993e2f2ca1985fcad3b9d15f6cba8a0b3</originalsourceid><addsrcrecordid>eNp9kcFu1DAQhiMEEkvhxAuMxAWEUsb2btbmZiXOxsKxo8RFKpcom41Fq9JtEyrUG4_QJ-lD8SSk3XLlNJqZ7___wx9FbwkeE0T66fv-8pgu2brl7Fm0IChETDARz6MF0jWPkTL6Mno1TeeI8w_5Irr_UnqagbQZ-GrFoDzx0mtnG6hqlenUQ-VcDVXePDKuAW2hlNYbBakyBsxpWRWulFCrVOmv2m6g0Jviz--7zDUKfKFqWZ0-imWT-s8PF8idzeS3OUaB9tJoaSUYbXNXanifa_MBytQgRQ5VIWcXrTX4WkvzOnoRuotpePM0j6KTXPm0iI3b6FSauCd8zeJtN-woxT7M2zIE0XOkIkESSN-vu7AUgg000L4jgq9C3-3YVuzIKiT9tuMdbtlR9O7gezXur2-G6Wd7vr8ZL-fIlghMEsZXyGfq44Hqx_00jUNor8azH9142xJsHwpp50Lap0Jmmh3oX2cXw-3_0LZw9p_qL3I1gQQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1906638508</pqid></control><display><type>article</type><title>KMT2D AND TP53 MUTATIONS PREDICT POOR PFS AND OS IN MANTLE CELL LYMPHOMA RECEIVING HIGH‐DOSE THERAPY AND ASCT: THE FONDAZIONE ITALIANA LINFOMI (FIL) MCL0208 PHASE III TRIAL</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Ferrero, S. ; Rossi, D. ; Bruscaggin, A. ; Evangelista, A. ; Di Rocco, A. ; Spina, V. ; Stefoni, V. ; Ghione, P. ; Barbero, D. ; Monitillo, L. ; Gomes Da Silva, M. ; Santoro, A. ; Molinari, A. ; Ferreri, A. ; Piccin, A. ; Cortelazzo, S. ; Ladetto, M. ; Gaidano, G.</creator><creatorcontrib>Ferrero, S. ; Rossi, D. ; Bruscaggin, A. ; Evangelista, A. ; Di Rocco, A. ; Spina, V. ; Stefoni, V. ; Ghione, P. ; Barbero, D. ; Monitillo, L. ; Gomes Da Silva, M. ; Santoro, A. ; Molinari, A. ; Ferreri, A. ; Piccin, A. ; Cortelazzo, S. ; Ladetto, M. ; Gaidano, G.</creatorcontrib><identifier>ISSN: 0278-0232</identifier><identifier>EISSN: 1099-1069</identifier><identifier>DOI: 10.1002/hon.2437_83</identifier><language>eng</language><publisher>Chichester: Wiley Subscription Services, Inc</publisher><subject>Lymphoma ; Mantle ; Mantle cell lymphoma ; Mutation ; p53 Protein ; Therapy</subject><ispartof>Hematological oncology, 2017-06, Vol.35 (S2), p.94-95</ispartof><rights>2017 The Authors. published by John Wiley & Sons, Ltd.</rights><rights>2017 The Authors. Hematological Oncology published by John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1873-baed220cf1874ff9c8029601f1cc7af4993e2f2ca1985fcad3b9d15f6cba8a0b3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fhon.2437_83$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fhon.2437_83$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids></links><search><creatorcontrib>Ferrero, S.</creatorcontrib><creatorcontrib>Rossi, D.</creatorcontrib><creatorcontrib>Bruscaggin, A.</creatorcontrib><creatorcontrib>Evangelista, A.</creatorcontrib><creatorcontrib>Di Rocco, A.</creatorcontrib><creatorcontrib>Spina, V.</creatorcontrib><creatorcontrib>Stefoni, V.</creatorcontrib><creatorcontrib>Ghione, P.</creatorcontrib><creatorcontrib>Barbero, D.</creatorcontrib><creatorcontrib>Monitillo, L.</creatorcontrib><creatorcontrib>Gomes Da Silva, M.</creatorcontrib><creatorcontrib>Santoro, A.</creatorcontrib><creatorcontrib>Molinari, A.</creatorcontrib><creatorcontrib>Ferreri, A.</creatorcontrib><creatorcontrib>Piccin, A.</creatorcontrib><creatorcontrib>Cortelazzo, S.</creatorcontrib><creatorcontrib>Ladetto, M.</creatorcontrib><creatorcontrib>Gaidano, G.</creatorcontrib><title>KMT2D AND TP53 MUTATIONS PREDICT POOR PFS AND OS IN MANTLE CELL LYMPHOMA RECEIVING HIGH‐DOSE THERAPY AND ASCT: THE FONDAZIONE ITALIANA LINFOMI (FIL) MCL0208 PHASE III TRIAL</title><title>Hematological oncology</title><subject>Lymphoma</subject><subject>Mantle</subject><subject>Mantle cell lymphoma</subject><subject>Mutation</subject><subject>p53 Protein</subject><subject>Therapy</subject><issn>0278-0232</issn><issn>1099-1069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kcFu1DAQhiMEEkvhxAuMxAWEUsb2btbmZiXOxsKxo8RFKpcom41Fq9JtEyrUG4_QJ-lD8SSk3XLlNJqZ7___wx9FbwkeE0T66fv-8pgu2brl7Fm0IChETDARz6MF0jWPkTL6Mno1TeeI8w_5Irr_UnqagbQZ-GrFoDzx0mtnG6hqlenUQ-VcDVXePDKuAW2hlNYbBakyBsxpWRWulFCrVOmv2m6g0Jviz--7zDUKfKFqWZ0-imWT-s8PF8idzeS3OUaB9tJoaSUYbXNXanifa_MBytQgRQ5VIWcXrTX4WkvzOnoRuotpePM0j6KTXPm0iI3b6FSauCd8zeJtN-woxT7M2zIE0XOkIkESSN-vu7AUgg000L4jgq9C3-3YVuzIKiT9tuMdbtlR9O7gezXur2-G6Wd7vr8ZL-fIlghMEsZXyGfq44Hqx_00jUNor8azH9142xJsHwpp50Lap0Jmmh3oX2cXw-3_0LZw9p_qL3I1gQQ</recordid><startdate>201706</startdate><enddate>201706</enddate><creator>Ferrero, S.</creator><creator>Rossi, D.</creator><creator>Bruscaggin, A.</creator><creator>Evangelista, A.</creator><creator>Di Rocco, A.</creator><creator>Spina, V.</creator><creator>Stefoni, V.</creator><creator>Ghione, P.</creator><creator>Barbero, D.</creator><creator>Monitillo, L.</creator><creator>Gomes Da Silva, M.</creator><creator>Santoro, A.</creator><creator>Molinari, A.</creator><creator>Ferreri, A.</creator><creator>Piccin, A.</creator><creator>Cortelazzo, S.</creator><creator>Ladetto, M.</creator><creator>Gaidano, G.</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7QP</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>201706</creationdate><title>KMT2D AND TP53 MUTATIONS PREDICT POOR PFS AND OS IN MANTLE CELL LYMPHOMA RECEIVING HIGH‐DOSE THERAPY AND ASCT: THE FONDAZIONE ITALIANA LINFOMI (FIL) MCL0208 PHASE III TRIAL</title><author>Ferrero, S. ; Rossi, D. ; Bruscaggin, A. ; Evangelista, A. ; Di Rocco, A. ; Spina, V. ; Stefoni, V. ; Ghione, P. ; Barbero, D. ; Monitillo, L. ; Gomes Da Silva, M. ; Santoro, A. ; Molinari, A. ; Ferreri, A. ; Piccin, A. ; Cortelazzo, S. ; Ladetto, M. ; Gaidano, G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1873-baed220cf1874ff9c8029601f1cc7af4993e2f2ca1985fcad3b9d15f6cba8a0b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Lymphoma</topic><topic>Mantle</topic><topic>Mantle cell lymphoma</topic><topic>Mutation</topic><topic>p53 Protein</topic><topic>Therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ferrero, S.</creatorcontrib><creatorcontrib>Rossi, D.</creatorcontrib><creatorcontrib>Bruscaggin, A.</creatorcontrib><creatorcontrib>Evangelista, A.</creatorcontrib><creatorcontrib>Di Rocco, A.</creatorcontrib><creatorcontrib>Spina, V.</creatorcontrib><creatorcontrib>Stefoni, V.</creatorcontrib><creatorcontrib>Ghione, P.</creatorcontrib><creatorcontrib>Barbero, D.</creatorcontrib><creatorcontrib>Monitillo, L.</creatorcontrib><creatorcontrib>Gomes Da Silva, M.</creatorcontrib><creatorcontrib>Santoro, A.</creatorcontrib><creatorcontrib>Molinari, A.</creatorcontrib><creatorcontrib>Ferreri, A.</creatorcontrib><creatorcontrib>Piccin, A.</creatorcontrib><creatorcontrib>Cortelazzo, S.</creatorcontrib><creatorcontrib>Ladetto, M.</creatorcontrib><creatorcontrib>Gaidano, G.</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Hematological oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ferrero, S.</au><au>Rossi, D.</au><au>Bruscaggin, A.</au><au>Evangelista, A.</au><au>Di Rocco, A.</au><au>Spina, V.</au><au>Stefoni, V.</au><au>Ghione, P.</au><au>Barbero, D.</au><au>Monitillo, L.</au><au>Gomes Da Silva, M.</au><au>Santoro, A.</au><au>Molinari, A.</au><au>Ferreri, A.</au><au>Piccin, A.</au><au>Cortelazzo, S.</au><au>Ladetto, M.</au><au>Gaidano, G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>KMT2D AND TP53 MUTATIONS PREDICT POOR PFS AND OS IN MANTLE CELL LYMPHOMA RECEIVING HIGH‐DOSE THERAPY AND ASCT: THE FONDAZIONE ITALIANA LINFOMI (FIL) MCL0208 PHASE III TRIAL</atitle><jtitle>Hematological oncology</jtitle><date>2017-06</date><risdate>2017</risdate><volume>35</volume><issue>S2</issue><spage>94</spage><epage>95</epage><pages>94-95</pages><issn>0278-0232</issn><eissn>1099-1069</eissn><cop>Chichester</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/hon.2437_83</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0278-0232 |
| ispartof | Hematological oncology, 2017-06, Vol.35 (S2), p.94-95 |
| issn | 0278-0232 1099-1069 |
| language | eng |
| recordid | cdi_proquest_journals_1906638508 |
| source | Wiley Online Library Journals Frontfile Complete |
| subjects | Lymphoma Mantle Mantle cell lymphoma Mutation p53 Protein Therapy |
| title | KMT2D AND TP53 MUTATIONS PREDICT POOR PFS AND OS IN MANTLE CELL LYMPHOMA RECEIVING HIGH‐DOSE THERAPY AND ASCT: THE FONDAZIONE ITALIANA LINFOMI (FIL) MCL0208 PHASE III TRIAL |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T01%3A23%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=KMT2D%20AND%20TP53%20MUTATIONS%20PREDICT%20POOR%20PFS%20AND%20OS%20IN%20MANTLE%20CELL%20LYMPHOMA%20RECEIVING%20HIGH%E2%80%90DOSE%20THERAPY%20AND%20ASCT:%20THE%20FONDAZIONE%20ITALIANA%20LINFOMI%20(FIL)%20MCL0208%20PHASE%20III%20TRIAL&rft.jtitle=Hematological%20oncology&rft.au=Ferrero,%20S.&rft.date=2017-06&rft.volume=35&rft.issue=S2&rft.spage=94&rft.epage=95&rft.pages=94-95&rft.issn=0278-0232&rft.eissn=1099-1069&rft_id=info:doi/10.1002/hon.2437_83&rft_dat=%3Cproquest_cross%3E1906638508%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1906638508&rft_id=info:pmid/&rfr_iscdi=true |